Life Sciences
Software Solutions

DXC RIM.AI helps you accelerate regulatory submissions for new therapies, devices and medicines in global markets. FirstPoint RIM.AI product suite is used by 500+ clients globally for their regulatory submissions. To cite just a couple of examples, among our clients we have seen zero refusal to file (RTF) for on-time, within budget submissions, and15% productivity gains on IND/NDA application compilation, submission and regulatory approvals. With our Total Regulatory Solution Suite, you can simultaneously publish and submit new drug applications in multiple markets and in compliance with a variety of regulatory formats, saving time and increasing productivity.

DXC Clinical Development Accelerators help life sciences organizations optimize clinical trials. Outcomes to expect from our Clinical Development Accelerators are:  

• Faster clinical trial enrollment with enhanced patient matching
• The ability to scale clinical trials globally
• Performance tracking of each CRA
• Accelerated clinical research analytics

AI can make multiple contributions to drug development and discovery, from analyzing large biological data sets to identify potential drug targets, to performing virtual screening for finding molecules suitable to becoming drugs, to finding new uses for old drugs. It can help lower costs by reducing failed experiments and trials.

DXC combines our domain knowledge in pharma / regulatory / clinical trials with AI/data/automation consulting. Among our consulting engagements, we have helped pharma companies accelerate regulatory processes using generative AI, and improved the efficiency of clinical trial design and operations using analytics and AI techniques. Overall, we have a strong ability to provide AI consulting in life sciences, especially around regulatory affairs, clinical trial operations, real‑world evidence, advanced analytics and enterprise modernization.

DXC provides a pharmacovigilance technology solution called ClinicalWorks. It is a pharmaceutical safety information management solution specifically designed for the pharmaceutical industry, for Adverse Drug Reaction (ADR) Tracking and Reporting. It supports compliance with domestic and international regulations (EMA, FDA, etc.) and supports both cloud and on-premises formats. This package is a condensation of the knowledge that DXC has supported in the pharmaceutical field for nearly 30 years.

We are in the process of expanding DXC ClinicalWorks, which has proven its effectiveness in Japan, to other markets. It is launching in the EU this year, and following that to the US, China, South Korea and Taiwan. Our global rollout features multilingual support.

You can file all at once across priority markets instead of waiting for approvals one by one, leverage accelerated pathways like the FDA’s Fast Track and submit pre-submission dossiers. AI tools and services from DXC can help you automate regulatory submission prep and manage different dossier formats. When it comes to the supply chain aspect, you can pursue cold chain readiness for temperature-sensitive biologics. DXC can support many of your efforts, including helping you coordinate real-time supply and demand globally.